Medication

FDA OKs First Cancer Drug by Genetic Type, Not Organ of Origin

FDA OKs First Cancer Drug by Genetic Type, Not Organ of Origin

MERCK KEYTRUDA, THIS IS BIG NEWS! FDA anonounces for the first time an approval of a CANCER drug that targets genetic biomarkers anywhere in the body, verses a specific body part or area of the body.

Top 20 Cancer Drugs

Top 20 Cancer Drugs

The face of cancer drugs has changed dramatically over the years. Nearly all of the top pharmaceutical companies are currently manufacturing oncology specific drugs or have high hopes with cancer-related drugs in their pipeline. Here is a list that is always changing but these are the top-grossing drugs...

Merck’s Keytruda cancer drug records sales surge

Merck’s Keytruda cancer drug records sales surge

Congratulations to Merck for the success of their Keytruda drug. Sales reflect the hope and success many are having with this immunotherapy medicine. Ever since former President Jimmy Carter announced he was "Cancer Free" at age 91, Keytruda has been referred to as the Presidents cancer drug. GREAT to...

Cancer Pill Gleevec Keeps Patients Alive and Well for a Decade

Cancer Pill Gleevec Keeps Patients Alive and Well for a Decade

Congratulations to Novartis on the success of Gleevec in treating chronic mylegenous leukemia (CML). 83% of people using it daily living on average an additional 10-years plus is the dream of every cancer patient.

Big pharma faces costly setback in cancer fight

Big pharma faces costly setback in cancer fight

Investors lose billions as immunotherapies fall short of high expectations When Cary Parton pulled a back muscle playing golf four years ago, he hardly gave it a second thought. But after several fruitless trips to a chiropractor.

Biden to tackle broad range of cancer issues, including drug prices, after leaving White House

Biden to tackle broad range of cancer issues, including drug prices, after leaving White House

Vice President Biden, who led the Obama administration's "cancer moonshot" initiative, will create a nonprofit organization to grapple with a broad range of cancer issues, including the high cost of cancer drugs.